Predictors of Mortality among United States Veterans with Human Immunodeficiency Virus and Hepatitis C Virus Coinfection

Table 4

Association of HCV treatment with mortality by virologic response status in multivariate model.

Category	𝑁	HR (95% CI)*
No HCV treatment	4,790	Ref.
Treated—no VR	116	0.40 (0.16–0.96)
Treated—VR	21	0.45 (0.06–3.20)
No HCV RNA data	332	0.41 (0.25–0.68)

VR: virologic response.
*HRs were similarly adjusted as in Table 3.